Obesity News

Once-daily liraglutide was not associated with greater weight loss for youths with obesity and Prader-Willi syndrome compared with placebo, according to a study published in The Journal of Clinical Endocrinology & Metabolism.

ObesityWeek will be held Nov. 1 to 4 in San Diego, with a broad theme of eradicating treatment barriers in endocrinology.

Phenomix Sciences has launched their Phenomix Sciences Obesity Platform, a set of data and tools that personalize obesity treatments.

BOSTON — In this Healio video exclusive, Juan P. Frias, MD, discusses his presentation on newer treatment options for type 2 diabetes at the Cardiometabolic Health Congress.

BOSTON — In this Healio video exclusive, a co-chair of the Cardiometabolic Health Congress discusses various highlights from the first 2.5 days of the meeting.

BOSTON — So-called pre-obesity, or a BMI between 25 and 30 kg/m2, is associated with all-cause and cause-specific mortality similar to overt obesity and treatment should begin early to reduce cardiometabolic risk, according to a speaker.

The AGA has released its first guideline endorsing the use of four medications for obesity management, when paired with lifestyle interventions, for patients who have failed to lose weight with diet and exercise alone.

Increasing BMI in young adult men is strongly associated with early atrial fibrillation as well as later worse clinical outcomes, including incident HF, stroke and all-cause mortality, among those diagnosed with AF, researchers reported.

The 2022 Cardiometabolic Health Congress will return in-person to Boston with the latest updates spanning all aspects of cardiometabolic health, including CVD, diabetes, kidney disease, lipid and lifestyle management and obesity.

With Obesity Medicine Association’s Fall Summit right around the corner, conference attendees — just like myself — are taking a look at the schedule and planning their 2022 conference experience.